Suizidversuch durch intravenöse Injektion
von Metasystox®

Zusammenfassung

Wir berichten über den seltenen Fall eines 27jährigen Mannes, der sich in suizidaler Absicht 30 ml Metasystox® (Demeton-S-methyl) intravenös appliziert hatte. Neben der raschen Entwicklung der akuten cholinergen Symptome, kam es zu einer frühzeitigen lokalen Infektion im Injektionsbereich der linken Cubitalvenen, die einen chirurgischen Eingriff mit ausgedehntem Débridement erforderlich machte. Der Patient entwickelte in der dritten Behandlungswoche eine Rhabdomyolyse mit akutem Nierenversagen sowie einen Anstieg der Leberenzyme. Abschließend zeigte sich als neurologische Manifestation der Organophosphat-Vergiftung ein Intermediärsyndrom.

Abstract

A 27-year old man was admitted to the hospital after having attempted suicide by injection of 30 ml of metasystox (demeton-s-methyl), an organophosphate compound, in a cubital vein of the left arm. He was suffering from the typical cholinergic symptoms. Local examination of the injection site revealed a local inflammation extending from the middle of the left upper arm to the distal forearm. Surgical débridement became necessary. In the third week of treatment he developed a rhabdomyolysis (CK 66.300 U/l) with an acute renal failure and needed haemodialysis. Later he showed signs of an intermediate syndrome.

Schlüsselwörter

Metasystox - Organophosphate - Intravenös - Rhabdomyolyse - Akutes Nierenversagen - Intermediärsyndrom

Key words

Metasystox - Organophosphate - Intravenous - Rhabdomyolysis - Acute renal failure - Intermediate syndrome

Literatur

• 1 Abend Y, Goland S, Evron E, Sthoeger Z M, Geltner D. Acute renal failure complicating organophosphate intoxication.  Ren Fail. 1994;  16 415-417
• 2 Albright R K, Kram B W, White R P. Malathion exposure associated with acute renal failure.  JAMA. 1983;  250 2469
• 3 Besser R, Gutmann L, Weilemann L S. Inactivation of end-plate acetylcholinesterase during the course of organophosphate intoxications.  Arch Toxicol. 1989;  63 412-415
• 4 Besser R, Gutmann L, Dillmann U, Weilemann L S, Hopf H C. End-plate dysfunction in acute organophosphate intoxication.  Neurology. 1989;  39 561-567
• 5 Besser R, Weilemann L S, Gutmann L. Efficacy of obidoxime in human organophosphorus poisoning: determination by neuromuscular transmission studies.  Muscle Nerve. 1995;  18 15-22
• 6 Betrosian A, Balla M, Kafiri G, Kofinas G, Makri R, Kakouri A. Multiple systems organ failure from organophosphate poisoning.  Clin Toxicol. 1995;  33 257-260
• 7 Brown M A, Brix K A. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents.  J Appl Toxicol. 1998;  18 393-408
• 8 Eigenberg D A, Pazdernik T L, Doull J. Hemoperfusion and pharmacokinetic studies with parathion and paraoxon in the rat and dog.  Drug Metab Dispos. 1983;  11 366-370
• 9 Eigenberg D A, Pazdernik T L, Doull J. Hemoperfusion and pharmacokinetic studies with methamidophos in the rat.  Fundam Appl Toxicol. 1983;  3 496-501
• 10 Güven M, Ünlühizarci K, Göktas Z, Kurtoglu S. Intravenous organophosphate injection: an unusual way of intoxikation.  Hum Exp Toxicol. 1997;  16 279-280
• 11 Güven M, Ata A. Intravenous organophosphate intoxication.Am J Emerg Med.  2000;  18 640-641
• 12 Hassan R M, Pesce A J, Sheng P, Hanenson I B. Correlation of serum pseudocholinesterase and clinical course in two patients poisoned with organophosphate insecticides.  Clin Toxicol. 1981;  18 401-406
• 13 Jamal G A. Neurological syndromes of organophosphorus compounds.  Adverse Drug React Toxicol Rev. 1997;  16 133-170
• 14 Lotti M, Becker C E, Aminoff J. Organophosphate polyneuropathy: pathogenesis and prevention.  Neurology (Clev). 1984;  34 658-662
• 15 Moretto A, Lotti M. Poisoning by organophosphorus insecticides and sensory neuropathy.  J Neurol Neurosurg Psychiatry. 1998;  64 463-468
• 16 Nishioka S A. Parenteral injection of organophosphate insecticide.  Rev Paul Med. 1994;  112 561-563
• 17 Panieri E, Krige J E, Bornman P C, Linton D M. Severe necrotizing pancreatitis caused by organophosphate poisoning.  J Clin Gastroenterol. 1997;  25 463-465
• 18 Peter J V, Cherian A M. Organic insecticides.  Anaesth Intensive Care. 2000;  28 11-21
• 19 Sedgwick E M, Senanayake N. Pathophysiology of the intermediate syndrome of organophosphate poisoning.  J Neurol Neurosurg Psychiatry. 1997;  62 201-202
• 20 Singh S, Sharma N. Neurological syndromes following organophosphate poisoning.  Neurol India. 2000;  48 308-313
• 21 Sundarka M K, Gupta H L, Parakh N, Saini M. Self injection if insecticide.  J Assoc Phys India. 2000;  48 856
• 22 Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Felgenhauer N, Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients.  Hum Exp Toxicol. 1997;  16 473-480
• 23 Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphorus poisoning.  Toxicol Lett. 1999;  107 233-239
• 24 Wedin G P, Pennente C M, Sachdev S S. Renal involvement in organophosphate poisoning.  JAMA. 1984;  252 1408
• 25 Worek F, Diepold C, Eyer P. Dimethylphosphoryl-inhibited human cholinesterase: inhibition, reactivation, and aging kinetics.  Arch Toxicol. 1999;  73 7-14
• 26 Young G D, Koplowitz I. Acute toxicity of cyclohexylmethylphosphonocluoridate (CMPF) in rhesus monkeys: serum biochemical and hematologic changes.  Arch Toxicol. 1995;  69 379-383